Novartis licences drugs to non-profit TB group

August 20, 2014

Swiss-based pharmaceuticals giant Novartis said Wednesday that it had signed a licensing deal with an international organisation that fights tuberculosis.

In a statement, the group said that the exclusive worldwide licensing agreement with the Global Alliance for TB Drug Development covered compounds discovered at the Novartis Institutes for Tropical Diseases.

All told, TB claimed 1.3 million lives worldwide last year, making it the deadliest disease after AIDS to be caused by a single infectious agent, according to the World Health Organization.

WHO figures show that there are 8.6 million cases of TB every year, and that drug-resistant forms are a huge emerging threat.

The disease is global, but its hotspots include China, India and the former communist countries of eastern Europe and central Asia.

The WHO last month called for a massive new international effort to try to wipe out TB by 2050.

Under the terms of agreement, Novartis will fully transfer its TB research and development programme to the Global Alliance.

The latter will take financial and operational responsibility for continued research, development, approval and distribution of compounds in the portfolio, Novartis said.

Pharmaceuticals in the deal include a novel class of drugs called indolcarboxamides that are active against drug sensitive and multi-resistant strains of TB.

Explore further: India must stop 'irrational' TB treatments: MSF

Related Stories

India must stop 'irrational' TB treatments: MSF

March 23, 2014
India must stop its doctors prescribing "irrational" treatments to cure tuberculosis, medical humanitarian group Medecins Sans Frontieres said Saturday, warning the practice is increasing drug-resistant strains of the disease.

New drug regimen speeds TB treatment

July 21, 2014
An experimental cocktail of three drugs can dramatically shorten the time it takes to treat patients infected with TB strains that are hard to cure with conventional antibiotics, according to research presented Monday at ...

Scientists establish proof-of-concept for host-directed tuberculosis therapy

June 27, 2014
In a new study published in Nature, scientists describe a new type of tuberculosis (TB) treatment that involves manipulating the body's response to TB bacteria rather than targeting the bacteria themselves, a concept called ...

Tuberculosis killed 1.3 million last year, WHO says (Update)

October 23, 2013
Tuberculosis claimed 1.3 million lives last year with drug-resistant forms of the infectious disease—the deadliest after AIDS—a huge global concern, the WHO warned Wedesday.

Drug resistance-associated genes: A cornerstone for the control and protection against tuberculosis

September 5, 2013
BGI in collaboration with Institute of Biophysics, Chinese Academy of Sciences, and other Chinese institutes, have completed the genome sequencing of 161 Mycobacterium tuberculosis that can cause an infectious disease tuberculosis ...

Myanmar receives high-tech TB detection machines

September 10, 2013
Myanmar on Tuesday received four state-of-the-art machines to detect drug-resistant tuberculosis, one of its major health problems.

Recommended for you

Google searches can be used to track dengue in underdeveloped countries

July 20, 2017
An analytical tool that combines Google search data with government-provided clinical data can quickly and accurately track dengue fever in less-developed countries, according to new research published in PLOS Computational ...

MRSA emerged years before methicillin was even discovered

July 19, 2017
Methicillin resistant Staphylococcus aureus (MRSA) emerged long before the introduction of the antibiotic methicillin into clinical practice, according to a study published in the open access journal Genome Biology. It was ...

New test distinguishes Zika from similar viral infections

July 18, 2017
A new test is the best-to-date in differentiating Zika virus infections from infections caused by similar viruses. The antibody-based assay, developed by researchers at UC Berkeley and Humabs BioMed, a private biotechnology ...

'Superbugs' study reveals complex picture of E. coli bloodstream infections

July 18, 2017
The first large-scale genetic study of Escherichia coli (E. coli) cultured from patients with bloodstream infections in England showed that drug resistant 'superbugs' are not always out-competing other strains. Research by ...

Ebola virus can persist in monkeys that survived disease, even after symptoms disappear

July 17, 2017
Ebola virus infection can be detected in rhesus monkeys that survive the disease and no longer show symptoms, according to research published by Army scientists in today's online edition of the journal Nature Microbiology. ...

Mountain gorillas have herpes virus similar to that found in humans

July 13, 2017
Scientists from the University of California, Davis, have detected a herpes virus in wild mountain gorillas that is very similar to the Epstein-Barr virus in humans, according to a study published today in the journal Scientific ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.